GPA-16 inhibitors are associated with the modulation of G protein signaling pathways or related cellular signaling mechanisms. These pathways are integral to how cells respond to external stimuli, and GPA-16 in C. elegans is part of this crucial signaling process. Pertussis Toxin (islet-activating protein) and Cholera Toxin A subunit are known to modulate G protein signaling by modifying the Gα subunits. Forskolin directly activates adenylyl cyclase, leading to increased cAMP levels, a common second messenger in G protein signaling pathways. Propranolol is a beta-adrenergic antagonist affecting GPCR-mediated pathways, potentially influencing the signaling environment of GPA-16. Y-27632, free base, NF449, U-73122, and Gallein target various components of G protein signaling cascades or their downstream effectors, potentially impacting pathways involving GPA-16.
AG1478 inhibits EGFR tyrosine kinase and Wortmannin is a PI3K inhibitor; both of these compounds affect signaling pathways that might intersect or interact with G protein-mediated pathways, including those mediated by GPA-16. 2-Deoxy-D-glucose, by interfering with cellular energy metabolism, can indirectly impact cellular signaling processes, potentially including those mediated by G proteins. These compounds are useful in studying the complex networks of cellular signaling, particularly in understanding the role and regulation of G proteins like GPA-16 in cellular communication processes. While these inhibitors and modulators do not target GPA-16 directly, their effects on the broader signaling pathways provide a context for understanding the functional role of GPA-16 in G protein-mediated signal transduction. This understanding is crucial for comprehending how cells interpret and respond to a multitude of signals in their environment, which is fundamental to cellular biology and the understanding of complex biological systems.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Inhibits G protein-coupled receptor (GPCR) signaling by ADP-ribosylating the Gαi subunit, potentially influencing pathways involving GPA-16. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
A beta-adrenergic receptor antagonist, affecting GPCR-mediated signaling and potentially influencing GPA-16 pathways. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibits ROCK kinase, part of downstream signaling of some GPCRs, potentially impacting GPA-16-related pathways. | ||||||
NF449 | 627034-85-9 | sc-478179 sc-478179A sc-478179B | 10 mg 25 mg 100 mg | $203.00 $469.00 $1509.00 | 1 | |
A potent Gαs inhibitor, possibly affecting signaling cascades related to or parallel with GPA-16. | ||||||
Gallein | 2103-64-2 | sc-202631 | 50 mg | $85.00 | 20 | |
Disrupts Gβγ signaling, potentially affecting pathways where GPA-16 is involved. | ||||||
Tyrphostin AG 1478 | 175178-82-2 | sc-200613 sc-200613A | 5 mg 25 mg | $96.00 $421.00 | 16 | |
An EGFR tyrosine kinase inhibitor, affecting signaling pathways that might interact with G protein-mediated pathways involving GPA-16. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
A glucose analog that interferes with glycolysis and cellular energy metabolism, potentially affecting signaling pathways including those mediated by GPA-16. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A phosphoinositide 3-kinase inhibitor, which could affect signaling pathways involving G proteins like GPA-16. | ||||||